CN Patent

CN109963874A — 靶向并通过辐射能分解癌症的癌症结合着色肽

Assigned to Cao Group Inc · Expires 2019-07-02 · 7y expired

What this patent protects

本发明公开一种化合物，其可包含在白光下人眼色彩可见的着色部分。该化合物可以构造为与癌细胞结合并使健康组织内的聚集最小化。该化合物可以容易地吸收一种波长的光，所述波长的光与发射所述波长或所述波长附近的光的辐射能量源相匹配。

USPTO Abstract

本发明公开一种化合物，其可包含在白光下人眼色彩可见的着色部分。该化合物可以构造为与癌细胞结合并使健康组织内的聚集最小化。该化合物可以容易地吸收一种波长的光，所述波长的光与发射所述波长或所述波长附近的光的辐射能量源相匹配。

Drugs covered by this patent

Patent Metadata

Patent number
CN109963874A
Jurisdiction
CN
Classification
—
Expires
2019-07-02
Drug substance claim
No
Drug product claim
No
Assignee
Cao Group Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.